Glossary Of Terms
|
Adrenalin |
See ‘Epinephrine’ |
|
Apnoea |
Cessation of breathing |
|
Arrhythmia |
Any variation from the normal rhythm of the Heart beat (also cardiac arrhythmia, ventricular, arrhythmia) |
|
Arteriosclerosis |
Hardening of the arteries (see Atherosclerosis) |
|
Atheroma |
Arteriosclerosis with degenerative associations |
|
Atherosclerosis |
Build-up of cholesterol causing blockage of the Larger arteries |
|
Benign |
Not malignant (see below), not recurrent |
|
Caffeine-naïve |
Individuals who have not been consuming caffeine for a certain period of time |
|
Carcinogen |
A substance which produces cancer |
|
Carcinoma |
A malignant new growth (see below) |
|
Cardiac |
Pertaining to the heart |
|
Cardiovascular |
Pertaining to the heart and blood vessels |
|
Catecholamines |
A family of hormones produced by the human body (see ‘Epinephrine’) |
|
Cholesterol |
A fat-like substance found in animal fats and oils |
|
Chromosome |
Structures present in each cell in higher organisms which comprise genes (see below). The number of chromosomes in each cell is predetermined for each species or organism |
|
Confounding factors |
Factors which may influence experimental results but which are not necessarily themselves key factors or being studied |
|
Congenital |
Existing at — and sometimes before birth |
|
DNA |
Deoxyribonucleic acid — a molecular double helix, composed of specifically arranged individual molecules. DNA represents the basic "building blocks" of genes |
|
Dose-related response |
Either the respective greater, or reduced response to a substance given in increasing or decreasing amounts |
|
Duodenum |
The initial length of the small intestine below the stomach |
|
Duration-related response |
The longer an individual is exposed to a test substance, the greater the increase in response to it (or, for example — the risk of disease) |
|
Epidemiology |
The study of disease occurrence in humans, and its relationship with associated factors |
|
Epinephrine |
A hormone produced by the adrenal glands. Epinephrine is one of a family of hormones known as catecholamines. Epinephrine is also known as adrenalin |
|
Ergogenic |
A substance with ergogenic effects improves work or exercise performance |
|
Fibrocystic breast disease |
A thickening of glandular tissue in the structure of the breast |
|
Gastrin |
A hormone which increases the flow of gastric juices |
|
Gastritis |
Inflammation of the stomach |
|
Gene |
The self-replicating biological unit of heredity, comprised on DNA (see above) |
|
Genotoxicity |
The effect of a substance on cellular genetic structure, leading to possible abnormalities |
|
Glycogen |
A carbohydrate energy source which is stored in the liver and muscles |
|
High density lipoprotein(HDL) |
The fraction of cholesterol believed to protect against the development of cardiovascular disease |
|
Hypertension |
Pertaining to high, or raising of, blood pressure |
|
In vitro |
Carried out in a test tube or on cultures (for example, an experiment may be carried out in vitro) |
|
In vivo |
Carried out in a living body (for example an experiment) |
|
Ischaemia |
Local and temporary blood deficiency (primarily due to contraction of a blood vessel) |
|
Lipid |
A fat substance |
|
Lipolysis |
The breakdown of fats, or lipids |
|
Low density lipoprotein (LDL) |
The fraction of cholesterol believed to be important in the development of adverse cardiovascular effects |
|
Lower Oesophageal Sphincter |
A short length of the oesophagus just above the stomach. Muscular control of this region by the diaphragm prevents stomach contents from moving back into the oesophagus |
|
Malignant |
A condition which tends to deteriorate |
|
Metabolism |
Bodily processes and chemical reactions by which an organism converts food to energy |
|
Methylxanthines |
The group of chemical compounds which includes caffeine |
|
Motility |
Pertaining to movement |
|
Mutagen |
A substance which includes genetic mutation |
|
Mutation |
A permanent change in form or genetic characteristic |
|
Myocardial infarction |
Heart attack |
|
Oesophagitis (Esophagitis) |
Inflammation of the oesophagus |
|
Oesophagus (Esophagus) |
The gullet, or food canal, through which food passes after swallowing, and which joins the stomach |
|
Osteoporosis |
A bone disease, primarily due to calcium depletion, which can lead to an increased likelihood of bone fracture |
|
Peptic |
Pertaining to digestion |
|
Placebo |
An inactive substance given as a control to study participants to compare with the effects of the substance under investigation |
|
Reflux |
A backward, or return flow |
|
Relative risk (RR) |
A measurement of risk for which 1 represents normal. RR less than 1 suggests no risk. RR greater than 1 indicates some level of risk. Only an RR of greater than 2 is generally considered to be relevant to real human risk |
|
Theophylline |
A body breakdown product of caffeine, only produced in very small amounts in humans |
|
Thermogenesis |
Literally, the production of heat. For example, fuel, or food burning by the human body |
|
Ulcer |
A type of sore, or tissue disintegration |
